A top official of the U.S. Customs Border Protection confirmed Wednesday that anyone working or investing in Canada’s cannabis industry will be treated as if they are an illegal drug trafficker.

Despite that Canada will have legal cannabis nationwide in a month, and that a majority of states have legalized cannabis to some extent, the plant remains illegal at the federal level. The U.S. government views foreigners working in the marijuana industry the same way they would someone working for an illegal drug cartel or as a dealer, regardless of their home nation’s laws.

The key to a quality product is consistency, according to Karen Parent, who works as the Chief Quality and Compliance Officer at Zenabis - one of Canada’s largest Licensed Cannabis Producers, writes Brandon Hicks.

Parent’s job, as she puts it, is to "provide quality assurance and compliance, guidance and strategy for the facilities to ensure that we protect our license and meet all of the requisite regulatory requirements within Canada, as well as internationally."

Southwestern Ontario is now a trailblazer in pot-growing.

London-area marijuana producer WeedMD is believed to be the first company in Canada to sell cannabis seeds abroad, a deal that puts the region at the forefront of an emerging international market, says the head of a marijuana trade association.

WeedMD, an Aylmer-based grower with a greenhouse operation in Strathroy, said Thursday it has exported seeds to Australia’s Medifarm, the country’s first-ever licensed medical marijuana producer.

Allan Rewak of the Cannabis Council of Canada, an industry group representing WeedMD and some of the country’s largest marijuana producers, called the Australia deal a “smart play.”

The parent company of marijuana producer Organigram Inc. has closed a $10-million investment deal with Hyasynth Biologicals, boosting its access to biotechnology that can produce cannabis' active chemical ingredients in a lab without needing a costly grow-op.

Organigram says Hyasynth's proprietary technology can produce active ingredients that occur naturally in the cannabis plant, called phytocannabinoids, using genetically engineered strains of yeast in a technique known as biofermentation. The Montreal-based biotech's enzymes and yeast strains have enabled them to produce cannabinoids such as cannabidiol, known as CBD, which can be used for cannabis-based products such as beverages or pharmaceutical products.

Canopy Growth's US$11 billion-plus market value is on par with Barrick Gold's, even though the mining firm is expected to post 20 times the sales this year. Canada’s cannabis companies are experiencing a rush of investment that’s making even some participants paranoid.

“You might argue our valuations are a little bit ahead of our skis,” said Paul Rosen, chief executive officer of Tidal Royalty Corp., which finances weed companies.

Despite Health Canada issuing 116 licenses through August, a small handful of growers could combine for more than 1.5 million kilograms of annual production.

CBD is growing in popularity for insomnia, anxiety, and chronic pain. But the cannabinoid has so more potential. Here’s Herb’s guide on the most underrated uses for CBD.

Everyone in the cannabis industry knows these days: the CBD market is booming. According to The Hemp Business Journal, a division of data analytics firm New Frontier Data, the CBD market will grow 700 percent between 2016 and 2022, reaching a total of $2.1 billion in sales. So why’s CBD so popular?

After some sober second thought the City of Calgary has ground out the idea of allowing people to use marijuana in four designated public areas once cannabis becomes legal next month. A proposal called for setting aside four areas in Ward 9 that would be exempt from Calgary's cannabis consumption bylaw.

The bylaw prohibits the consumption of recreational cannabis in any form in public places. But after hearing what it calls significant feedback from the community, the city says the idea of granting exemptions in Ward 9 has been scrapped.

The parent company of marijuana producer Organigram Inc. has closed a $10-million investment deal with Hyasynth Biologicals, boosting its access to biotechnology that can produce cannabis' active chemical ingredients in a lab without needing a costly grow-op.

Organigram says Hyasynth's proprietary technology can produce active ingredients that occur naturally in the cannabis plant, called phytocannabinoids, using genetically engineered strains of yeast in a technique known as biofermentation. The Montreal-based biotech's enzymes and yeast strains have enabled them to produce cannabinoids such as cannabidiol, known as CBD, which can be used for cannabis-based products such as beverages or pharmaceutical products.

When it comes to marijuana in Canada, it seems that after a long battle with the government, people who are lobbying for its legalization seem to be slowly reaching their goal. As of this year, 2018, even though recreational cannabis is still illegal, the situation might change quite soon. It’s obvious that the majority of people in Canada are in favor of legalization and that includes Prime Minister Justin Trudeau. In fact, one of the reasons he was elected was because of his firm stand that marijuana should be legal and he promised that this goal would be reached “by the summer”. This would be great news for many people who are serving jail time in Canada for selling and distributing cannabis. In fact, 58% of arrests considering controlled drugs and substances are for cannabis.